OAW28
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1614
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: OCCP ovarian cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2653399 PMID:8795574 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23415752 PMID:23839242 PMID:25230021 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30485824 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
OAW-28, OAW 28 |
|
|
CLO:CLO_0008228, EFO:EFO_0006704, CLDB:cl3756, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:515, BioSample:SAMN03472477, BioSample:SAMN10988017, cancercelllines:CVCL_1614, Cell_Model_Passport:SIDM00481, ChEMBL-Cells:CHEMBL3308479, ChEMBL-Targets:CHEMBL1075553, Cosmic:946360, Cosmic:1707570, Cosmic-CLP:946360, DepMap:ACH-000116, ECACC:85101601, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:946360, GEO:GSM659383, GEO:GSM711696, GEO:GSM827435, GEO:GSM887464, GEO:GSM888544, GEO:GSM1291143, GEO:GSM1374778, GEO:GSM1670292, IARC_TP53:27569, LiGeA:CCLE_007, LINCS_LDP:LCL-1698, PharmacoDB:OAW28_1178_2019, PRIDE:PXD030304, Progenetix:CVCL_1614, PubChem_Cell_line:CVCL_1614, Wikidata:Q54931684 |
|
|
CVCL_1614 |
2026-09-19 05:53:31 |
4 |
OCI-AML-5
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1620
|
Homo sapiens (Human)
|
Adult acute myeloid leukemia
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9096695 PMID:16408098 PMID:21989985 PMID:22460905 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26434589 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31395879 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
OCI/AML-5, OCI-AML5, OCI/AML5, OCI AML5, OCIAML5, Ontario Cancer Institute-Acute Myeloid Leukemia-5 |
|
|
BTO:BTO_0004621, CLO:CLO_0008236, EFO:EFO_0006707, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:215, BioSample:SAMN03472968, BioSample:SAMN03473389, BioSample:SAMN10988502, cancercelllines:CVCL_1620, Cell_Model_Passport:SIDM00461, ChEMBL-Cells:CHEMBL4523545, ChEMBL-Targets:CHEMBL4523576, Cosmic:787469, Cosmic:975291, Cosmic:1012111, Cosmic:1281346, Cosmic:1319548, Cosmic:2131553, Cosmic:2306234, Cosmic:2750856, Cosmic-CLP:1330983, DepMap:ACH-000065, DSMZ:ACC-247, DSMZCellDive:ACC-247, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1330983, GEO:GSM887470, GEO:GSM888550, GEO:GSM1374781, GEO:GSM1374782, GEO:GSM1446751, GEO:GSM1525023, GEO:GSM1670297, IARC_TP53:30133, LiGeA:CCLE_796, LINCS_LDP:LCL-1067, PharmacoDB:OCIAML5_1185_2019, PRIDE:PXD030304, Progenetix:CVCL_1620, PubChem_Cell_line:CVCL_1620, Wikidata:Q54931744 |
|
|
CVCL_1620 |
2026-09-19 05:53:33 |
14 |
OCI-AML-3
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1844
|
Homo sapiens (Human)
|
Adult acute myelomonocytic leukemia
|
Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2538684 PMID:12393637 PMID:16079892 PMID:16408098 PMID:21552520 PMID:22460905 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26434589 PMID:26589293 PMID:27397505 PMID:28109323 PMID:29491412 PMID:30285677 PMID:30629668 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31160637 PMID:31739141 PMID:36982453
|
Cancer cell line
|
Male |
OCI-Aml-3, OCI/AML-3, OCI-AML3, OCI/AML3, OCI AML3, OCIAML3, Ontario Cancer Institute-Acute Myeloid Leukemia-3 |
|
|
BTO:BTO_0004620, CLO:CLO_0009853, EFO:EFO_0006289, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioGRID_ORCS_Cell_line:214, BioSample:SAMN03473107, BioSample:SAMN10988470, cancercelllines:CVCL_1844, CCTCC:GDC0216, Cell_Model_Passport:SIDM00462, ChEMBL-Cells:CHEMBL4295392, ChEMBL-Targets:CHEMBL4296479, Cosmic:787467, Cosmic:975289, Cosmic:1012110, Cosmic:1127258, Cosmic:1245831, Cosmic:1319546, Cosmic:1557602, Cosmic:1582387, Cosmic:1696140, Cosmic:1779129, Cosmic:2131552, Cosmic:2306232, Cosmic:2750869, Cosmic-CLP:1290455, DepMap:ACH-000336, DSMZ:ACC-582, DSMZCellDive:ACC-582, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1290455, GEO:GSM482512, GEO:GSM887469, GEO:GSM888549, GEO:GSM1446756, GEO:GSM1525022, GEO:GSM1670296, GEO:GSM2716711, GEO:GSM2716712, GEO:GSM2716774, GEO:GSM2716775, GEO:GSM2716776, GEO:GSM2716777, IARC_TP53:30132, LiGeA:CCLE_569, LINCS_LDP:LCL-1066, Lonza:530, PharmacoDB:OCIAML3_1184_2019, Progenetix:CVCL_1844, PubChem_Cell_line:CVCL_1844, Ubigene:YC-C022, Wikidata:Q54931742 |
|
|
CVCL_1844 |
2026-09-19 05:53:33 |
291 |
OCUM-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_3084
|
Homo sapiens (Human)
|
Gastric signet ring cell adenocarcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1961183 PMID:15723654 PMID:20215515 PMID:21115893 PMID:22327936 PMID:22460905 PMID:24807215 PMID:25343454 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:29435981 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
OCUM1, Osaka City University Medical school-1 |
|
|
BTO:BTO_0005918, CLO:CLO_0037145, EFO:EFO_0006714, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03471652, BioSample:SAMN03473049, BioSample:SAMN10987922, cancercelllines:CVCL_3084, Cell_Model_Passport:SIDM00568, CGH-DB:131-1, Cosmic:1889265, Cosmic:2009531, Cosmic:2443794, Cosmic:2484967, Cosmic:2807640, Cosmic-CLP:1298358, DepMap:ACH-000247, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1298358, GEO:GSM552369, GEO:GSM827576, GEO:GSM887474, GEO:GSM888554, GEO:GSM1374795, GEO:GSM1670301, JCRB:JCRB0192, LiGeA:CCLE_111, LINCS_LDP:LCL-2002, PharmacoDB:OCUM1_1193_2019, PRIDE:PXD030304, Progenetix:CVCL_3084, Wikidata:Q54931820 |
|
|
CVCL_3084 |
2026-09-19 05:53:35 |
7 |
OCI-Ly19
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1878
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma germinal center B-cell type
|
Caution: While it was indicated to be EBV-positive (PubMed=20454443), this result has later been shown to be invalid (personal communication of Uphoff, Cord C.)., Population: Caucasian., From: Ontario Cancer Institute (OCI); Toronto; Canada., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8558920 PMID:8574164 PMID:19278952 PMID:20054396 PMID:20454443 PMID:20628145 PMID:22460905 PMID:23292937 PMID:23699601 PMID:25355872 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:26727417 PMID:26787899 PMID:27397505 PMID:28196595 PMID:29416618 PMID:29666304 PMID:30285677 PMID:30629668 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31160637 PMID:35839778
|
Cancer cell line
|
Female |
OCI-LY19, OCI-LY-19, OCI-Ly 19, OCI Ly19, OCILY-19, OCILY19, OCILy19, Ly19, LY19 |
|
|
CLO:CLO_0037052, EFO:EFO_0006709, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioGRID_ORCS_Cell_line:974, BioSample:SAMN03471654, BioSample:SAMN10988474, cancercelllines:CVCL_1878, Cell_Model_Passport:SIDM00460, ChEMBL-Cells:CHEMBL4482985, ChEMBL-Targets:CHEMBL4483262, CLS:305610, Cosmic:1079258, Cosmic:1086340, Cosmic:1295509, Cosmic:1329093, Cosmic:1629933, Cosmic:1945185, Cosmic:2276335, Cosmic-CLP:1330984, DepMap:ACH-000124, DSMZ:ACC-528, DSMZCellDive:ACC-528, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:1330984, GEO:GSM380132, GEO:GSM552460, GEO:GSM887471, GEO:GSM888551, GEO:GSM1035326, GEO:GSM1374786, GEO:GSM1670298, IARC_TP53:30134, LiGeA:CCLE_704, LINCS_LDP:LCL-1121, PharmacoDB:OCILY19_1186_2019, PRIDE:PXD030304, Progenetix:CVCL_1878, PubChem_Cell_line:CVCL_1878, Wikidata:Q54931771 |
|
|
CVCL_1878 |
2026-09-19 05:53:34 |
14 |
OE19
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1622
|
Homo sapiens (Human)
|
Esophageal adenocarcinoma
|
Characteristics: Contains a 100 fold amplification of ERBB2 (PubMed=15511476)., Part of: TCGA-110-CL cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9010035 PMID:15511476 PMID:16364037 PMID:20075370 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23795680 PMID:24083764 PMID:25070024 PMID:25877200 PMID:26512696 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31395879 PMID:34466148 PMID:35839778
|
Cancer cell line
|
Male |
OE-19, JROECL 19, JROECL19, OEC19 |
|
|
CLO:CLO_0008238, EFO:EFO_0002308, CLDB:cl3761, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03471032, BioSample:SAMN10988362, cancercelllines:CVCL_1622, Cell_Model_Passport:SIDM00479, ChEMBL-Cells:CHEMBL3308462, ChEMBL-Targets:CHEMBL1075555, Cosmic:871232, Cosmic:910079, Cosmic:978854, Cosmic:997860, Cosmic:1175878, Cosmic:1599342, Cosmic:1618819, Cosmic:1995600, Cosmic-CLP:910079, DepMap:ACH-000679, DSMZ:ACC-700, DSMZCellDive:ACC-700, ECACC:96071721, EGA:EGAS00001000978, GDSC:910079, GEO:GSM827301, GEO:GSM887475, GEO:GSM888555, GEO:GSM1264050, GEO:GSM1264051, GEO:GSM1264052, GEO:GSM1264053, GEO:GSM1264054, GEO:GSM1264092, GEO:GSM1264093, GEO:GSM1264094, GEO:GSM1264095, GEO:GSM1264096, GEO:GSM1670302, GEO:GSM7701391, GEO:GSM7701392, IARC_TP53:21600, IGRhCellID:OE19, LiGeA:CCLE_923, LINCS_LDP:LCL-1796, PharmacoDB:OE19_1194_2019, PRIDE:PXD030304, Progenetix:CVCL_1622, PubChem_Cell_line:CVCL_1622, Wikidata:Q54931862 |
|
|
CVCL_1622 |
2026-09-19 05:53:36 |
124 |
OE21
Resource Report
Resource Website
1+ mentions
|
ECACC Cat# 96062201, RRID:CVCL_2661
|
Homo sapiens (Human)
|
Esophageal squamous cell carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9010035 PMID:16364037 PMID:20215515 PMID:22460905 PMID:25877200 PMID:26512696 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
OE-21, JROECL 21, JROECL21 |
ECACC |
96062201 |
BTO:BTO_0004489, CLO:CLO_0008239, EFO:EFO_0002309, CLDB:cl5089, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:396, BioSample:SAMN03472891, BioSample:SAMN10989579, cancercelllines:CVCL_2661, Cell_Model_Passport:SIDM00478, Cosmic:1339912, Cosmic:1995601, Cosmic:2009522, Cosmic-CLP:1298359, DepMap:ACH-000544, ECACC:96062201, EGA:EGAS00001000978, GDSC:1298359, GEO:GSM827300, GEO:GSM888556, GEO:GSM1374796, GEO:GSM1374797, GEO:GSM1375727, GEO:GSM1375728, GEO:GSM1375729, GEO:GSM1375730, GEO:GSM1375739, GEO:GSM1375740, GEO:GSM1375741, GEO:GSM1375742, GEO:GSM1375751, GEO:GSM1375752, GEO:GSM1375753, GEO:GSM1375754, GEO:GSM1670303, IGRhCellID:OE21, LiGeA:CCLE_787, LINCS_LDP:LCL-1558, PharmacoDB:OE21_1195_2019, PRIDE:PXD030304, Progenetix:CVCL_2661, Wikidata:Q54931864 |
|
|
CVCL_2661 |
2026-09-19 05:53:36 |
2 |
NTERA-2
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0034
|
Homo sapiens (Human)
|
Embryonal carcinoma
|
Population: Caucasian., Part of: Human Protein Atlas, Cell Atlas panel.
|
PMID:3293662 PMID:6694356 PMID:16919167 PMID:16957166 PMID:25485619 PMID:25877200 PMID:26589293 PMID:35084545
|
Cancer cell line
|
Male |
NTera-2, Ntera-2, NTera 2, NTERA2, NTera2, N-Tera-2, NT-2, NT2 |
|
|
BTO:BTO_0000891, CLO:CLO_0008208, EFO:EFO_0002959, ArrayExpress:E-MTAB-2706, BioSample:SAMN03472969, CCRID:1101HUM-PUMC000019, ChEMBL-Cells:CHEMBL3308505, ChEMBL-Targets:CHEMBL614205, Cosmic:821809, Cosmic:2439936, Cosmic:2560242, Cosmic:2806394, Cosmic:2807075, DSMZ:ACC-527, DSMZCellDive:ACC-527, EGA:EGAS00001000610, GEO:GSM7701436, GEO:GSM7701437, IBRC:C10509, PharmacoDB:NTERA2_1167_2019, PRIDE:PXD030251, PubChem_Cell_line:CVCL_0034, RSCB:RSCB0150, Wikidata:Q17092091 |
cvcl_2777 |
|
CVCL_0034 |
2026-09-19 05:53:19 |
4 |
NTERA-2
Resource Report
Resource Website
1+ mentions
|
RSCB Cat# RSCB0150, RRID:CVCL_0034
|
Homo sapiens (Human)
|
Embryonal carcinoma
|
Population: Caucasian., Part of: Human Protein Atlas, Cell Atlas panel.
|
PMID:3293662 PMID:6694356 PMID:16919167 PMID:16957166 PMID:25485619 PMID:25877200 PMID:26589293 PMID:35084545
|
Cancer cell line
|
Male |
NTera-2, Ntera-2, NTera 2, NTERA2, NTera2, N-Tera-2, NT-2, NT2 |
RSCB |
RSCB0150 |
BTO:BTO_0000891, CLO:CLO_0008208, EFO:EFO_0002959, ArrayExpress:E-MTAB-2706, BioSample:SAMN03472969, CCRID:1101HUM-PUMC000019, ChEMBL-Cells:CHEMBL3308505, ChEMBL-Targets:CHEMBL614205, Cosmic:821809, Cosmic:2439936, Cosmic:2560242, Cosmic:2806394, Cosmic:2807075, DSMZ:ACC-527, DSMZCellDive:ACC-527, EGA:EGAS00001000610, GEO:GSM7701436, GEO:GSM7701437, IBRC:C10509, PharmacoDB:NTERA2_1167_2019, PRIDE:PXD030251, PubChem_Cell_line:CVCL_0034, RSCB:RSCB0150, Wikidata:Q17092091 |
cvcl_2777 |
|
CVCL_0034 |
2026-09-19 05:53:19 |
4 |
NUGC-3
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1612
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: JFCR45 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1370612 PMID:1778766 PMID:3172586 PMID:3325673 PMID:9290701 PMID:15723654 PMID:15767549 PMID:19132987 PMID:20164919 PMID:20215515 PMID:22460905 PMID:24807215 PMID:25343454 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29435981 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
NUGC3, NU-GC-3, Nagoya University-Gastric Cancer-3 |
|
|
BTO:BTO_0002597, CLO:CLO_0037144, EFO:EFO_0006702, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:397, BioSample:SAMN03473123, BioSample:SAMN10988359, cancercelllines:CVCL_1612, Cell_Model_Passport:SIDM00572, CGH-DB:134-1, ChEMBL-Cells:CHEMBL3307562, ChEMBL-Targets:CHEMBL614208, Cosmic:801341, Cosmic:877046, Cosmic:908455, Cosmic:918499, Cosmic:968351, Cosmic:1187288, Cosmic:1518256, Cosmic:1995599, Cosmic:2484968, Cosmic:2807638, Cosmic-CLP:908455, DepMap:ACH-000911, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:908455, GEO:GSM552367, GEO:GSM827405, GEO:GSM828828, GEO:GSM844666, GEO:GSM887462, GEO:GSM888542, GEO:GSM1374776, GEO:GSM1670287, IARC_TP53:973, JCRB:JCRB0822, LiGeA:CCLE_449, LINCS_LDP:LCL-1887, PharmacoDB:NUGC3_1173_2019, PRIDE:PXD030304, Progenetix:CVCL_1612, PubChem_Cell_line:CVCL_1612, Wikidata:Q54931160 |
|
|
CVCL_1612 |
2026-09-19 05:53:21 |
19 |
MOLP-2
Resource Report
Resource Website
|
RRID:CVCL_2123
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Characteristics: Produces IgD lambda., Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8148313 PMID:10936422 PMID:15215163 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:30285677 PMID:30894373 PMID:31068700 PMID:32123307
|
Cancer cell line
|
Male |
MOLP2 |
|
|
EFO:EFO_0006653, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, BioSample:SAMN03472938, BioSample:SAMN10988424, cancercelllines:CVCL_2123, Cell_Model_Passport:SIDM01690, CGH-DB:9146-4, DepMap:ACH-000453, DSMZ:ACC-607, DSMZCellDive:ACC-607, EGA:EGAS00001000610, GEO:GSM562815, GEO:GSM887332, GEO:GSM888408, IARC_TP53:28365, JCRB:JCRB1820, LiGeA:CCLE_676, PharmacoDB:MOLP2_953_2019, Progenetix:CVCL_2123, Wikidata:Q54906334 |
|
|
CVCL_2123 |
2026-09-19 05:45:28 |
0 |
MOG-G-UVW
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2614
|
Homo sapiens (Human)
|
Anaplastic astrocytoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3254724 PMID:7518347 PMID:7591247 PMID:20215515 PMID:25877200 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
MOG-GUVW, MOGGUVW, GO-G-UVW, G-UVW, UVW, Medical Oncology Glascow-Glioma-UVW |
|
|
CLO:CLO_0007818, CLDB:cl3513, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:945, BioSample:SAMN03470987, BioSample:SAMN10988296, cancercelllines:CVCL_2614, Cell_Model_Passport:SIDM00504, ChEMBL-Cells:CHEMBL3308137, ChEMBL-Targets:CHEMBL1075508, Cosmic:908145, Cosmic:2367539, Cosmic-CLP:908145, DepMap:ACH-001126, ECACC:86022703, EGA:EGAS00001000978, GDSC:90815, GEO:GSM827433, GEO:GSM1374687, GEO:GSM1670123, IARC_TP53:21510, LINCS_LDP:LCL-1397, PharmacoDB:MOGGUVW_949_2019, PRIDE:PXD030304, Progenetix:CVCL_2614, PubChem_Cell_line:CVCL_2614, Wikidata:Q54906313 |
|
|
CVCL_2614 |
2026-09-19 05:45:27 |
1 |
MOLT-3
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0624
|
Homo sapiens (Human)
|
Adult T acute lymphoblastic leukemia
|
Karyotypic information: Hypertetraploid karyotype (ATCC=CRL-1552)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:1086134 PMID:2846092 PMID:2985879 PMID:3159941 PMID:3518877 PMID:3856477 PMID:3874327 PMID:4547172 PMID:4567231 PMID:6220172 PMID:6600440 PMID:6978176 PMID:7630190 PMID:8547074 PMID:8608962 PMID:9738977 PMID:9787181 PMID:9933131 PMID:10739008 PMID:11986953 PMID:12623853 PMID:15472075 PMID:17170727 PMID:20215515 PMID:25877200 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35354797
|
Cancer cell line
|
Male |
Molt-3, MOLT 3, Molt 3, MOLT3, Molt3 |
|
|
BTO:BTO_0001081, CLO:CLO_0007824, CLO:CLO_0051008, EFO:EFO_0005265, CLDB:cl3519, CLDB:cl3521, CLDB:cl3522, CLDB:cl3523, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ATCC:CRL-1552, BCRC:60106, BEI_Resources:ARP-12187, BioSample:SAMN03470846, BioSample:SAMN03471394, BioSample:SAMN03472164, BioSample:SAMN03473404, BioSample:SAMN10989586, cancercelllines:CVCL_0624, Cell_Model_Passport:SIDM00153, ChEMBL-Cells:CHEMBL3307556, ChEMBL-Targets:CHEMBL614176, CLS:300116, Cosmic:724815, Cosmic:850193, Cosmic:913410, Cosmic:999756, Cosmic:1191701, Cosmic:1281377, Cosmic:1524845, Cosmic:2301561, Cosmic:2361367, Cosmic:2602923, DepMap:ACH-000964, DSMZ:ACC-84, DSMZCellDive:ACC-84, ECACC:90021901, GEO:GSM236793, GEO:GSM236829, GEO:GSM5137730, IGRhCellID:MOLT3, IZSLER:BS TCL 44, JCRB:JCRB9048, LiGeA:CCLE_717, PharmacoDB:MOLT3_957_2019, PRIDE:PXD023662, Progenetix:CVCL_0624, PubChem_Cell_line:CVCL_0624, RCB:RCB1164, Wikidata:Q54906351 |
|
|
CVCL_0624 |
2026-09-19 05:45:28 |
7 |
MOLT-4
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0013
|
Homo sapiens (Human)
|
Adult T acute lymphoblastic leukemia
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
|
PMID:165156 PMID:1765142 PMID:2041050 PMID:2140233 PMID:2144611 PMID:2846092 PMID:2985879 PMID:3159941 PMID:3335022 PMID:3874327 PMID:4547172 PMID:4567231 PMID:6181032 PMID:6198871 PMID:6200433 PMID:6582512 PMID:6954533 PMID:8127147 PMID:8316623 PMID:8547074 PMID:8558913 PMID:8641406 PMID:8957066 PMID:9331090 PMID:9510473 PMID:9685479 PMID:9787181 PMID:10071127 PMID:10700174 PMID:10739008 PMID:11021758 PMID:11226526 PMID:11416159 PMID:11986953 PMID:12068308 PMID:15472075 PMID:15748285 PMID:15901131 PMID:16408098 PMID:16957166 PMID:17088437 PMID:17117183 PMID:19372543 PMID:20164919 PMID:20215515 PMID:20922763 PMID:22068913 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23856246 PMID:23933261 PMID:24279929 PMID:24670534 PMID:24762992 PMID:25877200 PMID:26295583 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:28569787 PMID:30894373 PMID:31068700 PMID:31160637 PMID:31733513 PMID:32449352 PMID:35354797 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Male |
Molt-4, MOLT 4, Molt 4, MOLT.4, MOLT4, Molt4, GM02219, GM02219C, GM2219C, GM02219D |
|
|
BTO:BTO_0000873, CLO:CLO_0007825, CLO:CLO_0032246, CLO:CLO_0050992, EFO:EFO_0001220, MCCL:MCC:0000335, CLDB:cl3524, CLDB:cl3525, CLDB:cl3527, CLDB:cl3528, CLDB:cl3529, CLDB:cl3530, CLDB:cl3531, CLDB:cl3532, CLDB:cl4976, CLDB:cl5233, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, ATCC:CRL-1582, BCRC:60060, BCRJ:0176, BioSample:SAMN03470847, BioSample:SAMN03471400, BioSample:SAMN03472410, BioSample:SAMN03473319, BioSample:SAMN10988202, cancercelllines:CVCL_0013, CCRID:1101HUM-PUMC000043, CCRID:3101HUMTCHu224, CCRID:4201HUM-CCTCC00083, CCTCC:GDC0083, Cell_Model_Passport:SIDM00145, ChEMBL-Cells:CHEMBL3307557, ChEMBL-Targets:CHEMBL614177, CLS:300115, Coriell:GM02219, Cosmic:716176, Cosmic:721716, Cosmic:801730, Cosmic:850194, Cosmic:850381, Cosmic:875865, Cosmic:897451, Cosmic:905958, Cosmic:913409, Cosmic:919154, Cosmic:922677, Cosmic:932766, Cosmic:933547, Cosmic:974249, Cosmic:991545, Cosmic:999763, Cosmic:1012099, Cosmic:1019314, Cosmic:1044254, Cosmic:1070704, Cosmic:1071877, Cosmic:1082518, Cosmic:1092615, Cosmic:1115596, Cosmic:1118467, Cosmic:1127263, Cosmic:1130237, Cosmic:1151788, Cosmic:1175131, Cosmic:1175857, Cosmic:1176596, Cosmic:1226858, Cosmic:1305339, Cosmic:1312325, Cosmic:1330500, Cosmic:1483362, Cosmic:1509200, Cosmic:1524808, Cosmic:1639636, Cosmic:1664513, Cosmic:1811158, Cosmic:1998457, Cosmic:2039521, Cosmic:2165720, Cosmic:2361368, Cosmic:2560251, Cosmic:2602924, Cosmic-CLP:905958, dbMHC:48976, DepMap:ACH-001127, DSMZ:ACC-362, DSMZCellDive:ACC-362, ECACC:85011413, ECACC:94022544, EGA:EGAS00001000978, GDSC:905958, GEO:GSM2092, GEO:GSM50196, GEO:GSM50912, GEO:GSM236794, GEO:GSM236830, GEO:GSM743460, GEO:GSM750821, GEO:GSM799348, GEO:GSM799411, GEO:GSM887336, GEO:GSM888412, GEO:GSM1178423, GEO:GSM1178424, GEO:GSM1178425, GEO:GSM1181333, GEO:GSM1181349, GEO:GSM1670128, GEO:GSM1696583, GEO:GSM1696584, GEO:GSM1696585, GEO:GSM1696586, GEO:GSM2124644, GEO:GSM4471876, GEO:GSM5137731, GEO:GSM7701445, GEO:GSM7701446, IARC_TP53:27042, ICLC:HTL99025, IGRhCellID:MOLT4, IHW:IHW09226, IPD-IMGT/HLA:11094, IZSLER:BS TCL 85, JCRB:IFO50362, JCRB:JCRB9031, KCB:KCB 200940YJ, KCLB:21582, LINCS_LDP:LCL-1019, Lonza:810, NCBI_Iran:C149, NCI-DTP:MOLT-4, PharmacoDB:MOLT4_958_2019, PRIDE:PXD003539, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD018565, PRIDE:PXD023662, PRIDE:PXD030304, Progenetix:CVCL_0013, PubChem_Cell_line:CVCL_0013, RCB:RCB0206, SKY/M-FISH/CGH:2741, Ubigene:YC-C127, Wikidata:Q54906365 |
|
|
CVCL_0013 |
2026-09-19 05:45:28 |
318 |
MOR
Resource Report
Resource Website
|
RRID:CVCL_2618
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Caucasian.
|
PMID:3034934 PMID:7171457 PMID:7903701 PMID:25485619 PMID:25877200 PMID:26589293
|
Cancer cell line
|
Sex unspecified |
MOR/P |
|
|
EFO:EFO_0006655, ArrayExpress:E-MTAB-2706, BioSample:SAMN03472982, Cell_Model_Passport:SIDM01390, ECACC:84112312, EGA:EGAS00001000610, EGA:EGAS00001002554, PharmacoDB:MOR_961_2019, Wikidata:Q54906387 |
|
|
CVCL_2618 |
2026-09-19 05:45:30 |
0 |
MOR
Resource Report
Resource Website
|
ECACC Cat# 84112312, RRID:CVCL_2618
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Caucasian.
|
PMID:3034934 PMID:7171457 PMID:7903701 PMID:25485619 PMID:25877200 PMID:26589293
|
Cancer cell line
|
Sex unspecified |
MOR/P |
ECACC |
84112312 |
EFO:EFO_0006655, ArrayExpress:E-MTAB-2706, BioSample:SAMN03472982, Cell_Model_Passport:SIDM01390, ECACC:84112312, EGA:EGAS00001000610, EGA:EGAS00001002554, PharmacoDB:MOR_961_2019, Wikidata:Q54906387 |
|
|
CVCL_2618 |
2026-09-19 05:45:30 |
0 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
AddexBio Cat# T0016002/4922, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
AddexBio |
T0016002/4922 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-09-19 05:45:35 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
JCRB Cat# IFO50073, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
JCRB |
IFO50073 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-09-19 05:45:35 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
JCRB Cat# JCRB9008, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
JCRB |
JCRB9008 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-09-19 05:45:35 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
CCTCC Cat# GDC0032, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
CCTCC |
GDC0032 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-09-19 05:45:35 |
2876 |